TechSeeker Profile

Mallinckrodt Inc
Profile last edited on: 8/29/2013

NO Business Identifier is currently available for this company.
TS Type
N/A
Status
N/A
Year Founded
1840
Last Involved Year
2016

Key People / Management

Location Information

675 McDonnell Boulevard
St. Louis, MO 63042
   314 654 2000
   www.mallinckrodt.com

Public Profile

Mallinckrodt Pharmaceuticals, based in Dublin, Ireland with U.S. headquarters in St. Louis, Missouri, produces specialty pharmaceutical products including generic drugs and imaging agents. Mallinckrodt, LLC manufactures and distributes products used in diagnostic procedures, and in the treatment of pain and related conditions. It offers addiction treatment products, and specialty generics and pharmaceuticals; and active pharmaceutical ingredients, including medicinal narcotics, acetaminophen/paracetamol, stearates, phosphates, and peptides, as well as analytical research samples for pharmaceutical companies and analytical laboratories. The company also supplies medical isotope technetium-99m; and radiopharmaceuticals, and contrast media and delivery systems. It serves customers in the United States and internationally. The company was originally founded in 1867 and is based in Hazelwood, Missouri. Mallinckrodt Pharmaceuticals, based in Dublin, Ireland hasU.S. headquarters in St. Louis, Missouri, produces specialty pharmaceutical products including generic drugs and imaging agents. Recent histroy: In 2000 Tyco International acquired Mallinckrodt. Seven years later, in 2007 – Tyco Healthcare spun off and becomes Covidien, an independent company [9] The healthcare business units were spun off under the name Covidien. In 2011 – Covidien spun off Mallinckrodt Pharmaceuticals as a standalone public company. Shortly after acquiring CNS Therapeutics in 2012, Mallinckrodt spun off from Covidien and begins trading under ticker symbol MNK

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
USA
Employment
5,500
Revenue
$640.0M
Public/Private
Publicly Traded
Stock Info
NASDAQ : MNK
Received SBIR $$
No

Techseeker firm in the news

There are no news available.